| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; human; loading ...; fig 3c
| Kaindl J, Meiser I, Majer J, Sommer A, Krach F, Katsen Globa A, et al. Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual-Center Study Using Adherent Vitrification. Stem Cells Transl Med. 2019;8:247-259 pubmed publisher |
- flow cytometry; human; loading ...; fig 3a
| Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher |
| Krumm L, Pozner T, Kaindl J, Regensburger M, Günther C, Turan S, et al. Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in. Stem Cell Res. 2021;56:102520 pubmed publisher |
| Tsukamoto S, Nakade K, Wakabayashi T, Nakashima K, Takami M, Hemmi Y, et al. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing. Stem Cell Res. 2021;53:102363 pubmed publisher |
| Kuramochi Y, Awaya T, Matsuo Takasaki M, Takami M, An Y, Li J, et al. Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations. Stem Cell Res. 2021;53:102337 pubmed publisher |
| Dong T, Zhang S, Chang Y, Bai R, Jiang Y, Ma S, et al. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system. Stem Cell Res. 2021;51:102196 pubmed publisher |
| Leavens K, Liao C, Gagne A, Kishore S, Cardenas Diaz F, French D, et al. Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem Cell Res. 2020;50:102112 pubmed publisher |
| Ababneh N, Al Kurdi B, Barham R, Ali D, Sharar N, Abuarqoub D, et al. Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton's jelly samples. Stem Cell Res. 2020;49:102000 pubmed publisher |
| Ababneh N, Ali D, Barham R, Al Kurdi B, Sharar N, Al Hadidi S, et al. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem Cell Res. 2020;48:101967 pubmed publisher |
| Arai Y, Takami M, An Y, Matsuo Takasaki M, Hemmi Y, Wakabayashi T, et al. Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion. Stem Cell Res. 2020;45:101815 pubmed publisher |
| Dafinca R, Barbagallo P, Farrimond L, Candalija A, Scaber J, Ababneh N, et al. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Stem Cell Reports. 2020;14:892-908 pubmed publisher |
| Okubo T, Hayashi R, Shibata S, Kudo Y, Ishikawa Y, Inoue S, et al. Generation and validation of a PITX2-EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells. J Biol Chem. 2020;295:3456-3465 pubmed publisher |
| Maguire J, Gagne A, Gonzalez Alegre P, Davidson B, Shakkottai V, Gadue P, et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2019;34:101361 pubmed publisher |
| Gagne A, Maguire J, Gandre Babbe S, Chou S, Tasian S, Loh M, et al. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160 pubmed publisher |
| Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. Cell Stem Cell. 2018;23:123-131.e6 pubmed publisher |
| Slamecka J, McClellan S, Wilk A, Laurini J, Manci E, Hoerstrup S, et al. Induced pluripotent stem cells derived from human amnion in chemically defined conditions. Cell Cycle. 2018;17:330-347 pubmed publisher |
| Vazquez Arango P, Vowles J, Browne C, Hartfield E, Fernandes H, Mandefro B, et al. Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease. Nucleic Acids Res. 2016;44:10960-10973 pubmed |
| Handel A, Chintawar S, Lalic T, Whiteley E, Vowles J, Giustacchini A, et al. Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics. Hum Mol Genet. 2016;25:989-1000 pubmed publisher |
| Slamecka J, Salimova L, McClellan S, van Kelle M, Kehl D, Laurini J, et al. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions. Cell Cycle. 2016;15:234-49 pubmed publisher |
| Wattanapanitch M, Klincumhom N, Potirat P, Amornpisutt R, Lorthongpanich C, U Pratya Y, et al. Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages. PLoS ONE. 2014;9:e106952 pubmed publisher |
| Schinzel R, Ahfeldt T, Lau F, Lee Y, Cowley A, Shen T, et al. Efficient culturing and genetic manipulation of human pluripotent stem cells. PLoS ONE. 2011;6:e27495 pubmed publisher |
